LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

LLY

795.48

+0.43%↑

JNJ

152.14

-0.14%↓

ABBV

186.94

+0.72%↑

NVO

67.74

+0.61%↑

UNH

302.46

+0.12%↑

Search

Novocure Ltd

Closed

SectorHealthcare

17.05 -1.56

Overview

Share price change

24h

Current

Min

16.9

Max

17.42

Key metrics

By Trading Economics

Income

32M

-34M

Sales

-6.3M

155M

EPS

-0.31

Profit margin

-22.142

Employees

1,488

EBITDA

-24M

-35M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+92.84% upside

Dividends

By Dow Jones

Next Earnings

24 Jul 2025

Market Stats

By TradingEconomics

Market Cap

115M

1.9B

Previous open

18.61

Previous close

17.05

News Sentiment

By Acuity

50%

50%

165 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Novocure Ltd Chart

Past performance is not a reliable indicator of future results.

Related News

15 Oct 2024, 21:35 UTC

Major Market Movers

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

16 Oct 2024, 11:43 UTC

Earnings

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, J.B. Hunt, DJT, Novocure, and More -- Barrons.com

16 Oct 2024, 10:40 UTC

Earnings

These Stocks Are Moving the Most Today: ASML, Nvidia, United Airlines, J.B. Hunt, DJT, Novocure, Morgan Stanley, and More -- Barrons.com

16 Oct 2024, 09:27 UTC

Hot Stocks

Stocks to Watch Wednesday: ASML, Morgan Stanley, Novocure, TSM -- WSJ

Peer Comparison

Price change

Novocure Ltd Forecast

Price Target

By TipRanks

92.84% upside

12 Months Forecast

Average 33.4 USD  92.84%

High 40 USD

Low 27 USD

Based on 6 Wall Street analysts offering 12 month price targets forNovocure Ltd - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

6 ratings

4

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

16.31 / 18.14Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

165 / 380 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.